Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

BeOne Medicines Ltd. - Sponsored ADR (ONC) vs Vertex Pharmaceuticals Incorporated (VRTX)

BeOne Medicines Ltd. - Sponsored ADR and Vertex Pharmaceuticals Incorporated are both Biotechnology companies. Vertex Pharmaceuticals Incorporated is the larger, with a market value of $132.3B against $37.3B — 3.6× the size. Vertex Pharmaceuticals Incorporated trades at the lower P/E: 30.4× against 61.2×. BeOne Medicines Ltd. - Sponsored ADR grew revenue faster over the last twelve months: 34.4% against 10.2%. Vertex Pharmaceuticals Incorporated has the higher net margin (35.0% vs 10.7%) and the lower return on invested capital (24.1% vs 60.2%). Across the 22 metrics below, Vertex Pharmaceuticals Incorporated leads on 12 and BeOne Medicines Ltd. - Sponsored ADR on 10.

Valuation

Metric ONC VRTX Biotechnology median
P/E 61.16 30.36 7.88
P/S 6.57 10.61 11.47
P/B 7.78 6.59 2.52
Price to free cash flow 30.73 35.17 21.16
EV/EBITDA 34.08 25.17 0.74
EV/Sales 5.99 10.00 10.73
Earnings yield 1.64% 3.29% (28.84%)
Free cash flow yield 3.25% 2.84% (23.03%)

Profitability

Metric ONC VRTX Biotechnology median
Gross margin 88.89% 86.00% 65.16%
Operating margin 15.06% 37.95% 0.00%
Net margin 10.70% 35.00% 0.00%
Free cash flow margin 21.70% 30.16% 0.00%
Return on equity 14.66% 23.54% (57.72%)
Return on assets 8.47% 17.12% (49.22%)
Return on invested capital 60.22% 24.09% 0.00%

Growth

Metric ONC VRTX Biotechnology median
Revenue growth (TTM) 34.35% 10.23% 5.64%
EPS growth (last fiscal year) 141.34% 836.54% —
Revenue growth, 5-year CAGR 76.85% 14.10% 8.40%
Net income growth, 5-year CAGR 0.00% 7.83% 0.00%

Health

Metric ONC VRTX Biotechnology median
Debt to equity 0.17 0.00 0.00
Current ratio 3.41 3.19 4.73
Net debt to EBITDA (6.09) (1.51) 0.96

Dividend

Metric ONC VRTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ONC VRTX Biotechnology median
Market cap 37.25b 132.32b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack